NEW YORK (GenomeWeb News) – Mayo Clinic's Center for Translational Science Activities has seen its funding from the National Institutes of Health renewed for $64.6 million and for another five years.
Mayo will use the funding from the National Center for Research Resources' Clinical and Translational Science Awards to continue its ongoing efforts to develop new treatments and technologies, improve community health and healthcare delivery, and support a range of training and education programs for researchers.
Mayo also plans to use the funding to streamline regulatory compliance and support efforts, to provide design, biostatistic, and ethics support, and use informatics to integrate and facilitate clinical and translational research.
"In this time of belt-tightening, to receive nearly all that we applied for indicates the confidence of the NIH in the continued success of our CTSA," Mayo Clinic CTSA Director Professor Robert Rizza said in a statement.
Mayo said that its CTSA has been involved in 30 discoveries that have improved medical practice, has cut its have average approval time for studies in half, and has increased its Clinical Research Unit (CRU)-based studies by 20 percent.
The CTSA provides infrastructure and support for Mayo's four CRUs, which serve as institutional labs for clinical trials.